Track the Sabra Health Care REIT, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Real Estate sector, Sabra Health Care REIT, Inc. has logged 141 insider filings. Market capitalisation: €5bn. The latest transaction was disclosed on 26 March 2026 (Cession). Among the most active insiders: Costa Michael Lourenco. Every trade is openly available.
Analysts rate Sabra Health Care REIT, Inc. Buy (bullish), based on 14 analysts. Average price target: US$22.00.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 141 declarations
Sabra Health Care REIT, Inc. is a U.S.-listed real estate investment trust traded on the NASDAQ under the ticker SBRA. Headquartered in Tustin, California, Sabra is a self-managed and self-administered REIT focused on healthcare real estate in the United States and Canada. Its core appeal to investors is a specialized healthcare property platform rather than a broad-based property portfolio, with the company concentrating on assets tied to long-duration care needs and healthcare delivery infrastructure. ([ir.sabrahealth.com](https://ir.sabrahealth.com/investors/overview/default.aspx?utm_source=openai)) Sabra’s business model is built around owning, investing in, and in some cases financing healthcare-related real estate. The company describes itself as being led by former operators, which is meaningful in this niche: operational know-how can matter as much as capital allocation when selecting tenants, structuring leases, and underwriting facility-level risk. That background is especially relevant in healthcare real estate, where reimbursement dynamics, regulation, resident acuity, and operator quality can materially affect cash flow durability. ([sabrahealth.com](https://sabrahealth.com/about?utm_source=openai)) The portfolio is anchored by skilled nursing/transitional care facilities and senior housing communities, but it also includes behavioral health facilities, specialty hospitals, loans receivable, preferred equity investments, and joint ventures. As of March 31, 2026, Sabra reported 361 real estate properties held for investment, plus additional assets held for sale and financial investments. This structure gives the company multiple ways to deploy capital across healthcare property types while maintaining exposure to the secular tailwinds of an aging population and rising demand for care-oriented real estate. ([ir.sabrahealth.com](https://ir.sabrahealth.com/investors/news/news-details/2026/Sabra-Reports-First-Quarter-2026-Results-Reiterates-2026-Guidance/default.aspx?utm_source=openai)) From a competitive standpoint, Sabra competes in a specialized REIT universe where scale, operator relationships, and underwriting discipline are key differentiators. Its North American footprint, sector focus, and ability to combine property ownership with financing solutions give it a distinct profile versus more diversified REITs. The trade-off is that the company remains sensitive to healthcare operator performance and sector-specific regulatory and reimbursement pressures, particularly in skilled nursing. ([ir.sabrahealth.com](https://ir.sabrahealth.com/investors/overview/default.aspx?utm_source=openai)) Recent company developments underscore ongoing capital allocation activity. In first-quarter 2026, Sabra reported results and reiterated full-year 2026 guidance. It also disclosed fresh acquisitions in managed senior housing and a skilled nursing facility, alongside a preferred equity commitment for a senior housing development project, indicating that the company continues to source growth opportunities in its core niches. In addition, Sabra’s management presented at a major real estate securities conference in May 2026, reflecting continued investor outreach and market visibility. ([ir.sabrahealth.com](https://ir.sabrahealth.com/investors/news/news-details/2026/Sabra-Reports-First-Quarter-2026-Results-Reiterates-2026-Guidance/default.aspx?utm_source=openai))